USD 0.0
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 137.3 Thousand USD | 0.0% |
2022 | - USD | 0.0% |
2021 | - USD | -100.0% |
2020 | 716.87 Thousand USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | -100.0% |
2012 | 250.00 USD | -85.71% |
2011 | 1750.00 USD | 0.0% |
2010 | - USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 36.44 Thousand USD | -26.53% |
2024 Q2 | 32.16 Thousand USD | -11.73% |
2023 Q3 | 19.76 Thousand USD | -45.01% |
2023 Q2 | 35.94 Thousand USD | 33.11% |
2023 Q1 | 27 Thousand USD | 0.0% |
2023 FY | 137.3 Thousand USD | 0.0% |
2023 Q4 | 49.6 Thousand USD | 150.95% |
2022 Q1 | - USD | 0.0% |
2022 FY | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 Q1 | - USD | -100.0% |
2021 FY | - USD | -100.0% |
2020 Q4 | 103.22 Thousand USD | 0.0% |
2020 FY | 716.87 Thousand USD | 0.0% |
2019 FY | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | -100.0% |
2013 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2012 Q2 | - USD | -100.0% |
2012 Q4 | - USD | 0.0% |
2012 Q1 | 250.00 USD | 0.0% |
2012 FY | 250.00 USD | -85.71% |
2012 Q3 | - USD | 0.0% |
2011 Q4 | - USD | -100.0% |
2011 FY | 1750.00 USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q2 | 1500.00 USD | 0.0% |
2011 Q3 | 250.00 USD | -83.33% |
2010 Q4 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
The Amacore Group, Inc. | 28.82 Million USD | 99.524% |
Arem Pacific Corporation | 343.47 Thousand USD | 60.025% |
Assisted 4 Living, Inc. | 880.78 Thousand USD | 84.411% |
BioCorRx Inc. | 89.16 Thousand USD | -53.998% |
Bionik Laboratories Corp. | 1.8 Million USD | 92.394% |
Banyan Corp. | 5 Million USD | 97.256% |
Clearday, Inc. | 12.48 Million USD | 98.901% |
Dental Patient Care America, Inc. | 3.24 Million USD | 95.77% |
Quantum Medical Transport, Inc. | 1310.14 USD | -10380.178% |
Empower Clinics Inc. | 4.66 Million USD | 97.055% |
First Choice Healthcare Solutions, Inc. | 29.98 Thousand USD | -357.912% |
Selectis Health, Inc. | 36.78 Million USD | 99.627% |
Ethema Health Corporation | 5.34 Million USD | 97.431% |
HealthLynked Corp. | 5.72 Million USD | 97.601% |
HQDA Elderly Life Network Corp. | - USD | -Infinity% |
Healthcare Solutions Management Group, Inc. | 9.24 Million USD | 98.515% |
JRSIS Health Care Corporation | 3.46 Million USD | 96.034% |
Comjoyful International Company | - USD | -Infinity% |
Medical Facilities Corporation | 453.75 Million USD | 99.97% |
MedSmart Group Inc. | - USD | -Infinity% |
Nova Leap Health Corp. | 26.17 Million USD | 99.476% |
Nexteligent Holdings, Inc. | 351.66 Thousand USD | 60.956% |
PAO Group, Inc. | - USD | -Infinity% |
Primemd Inc. | 10.5 Million USD | 98.693% |
Raffles Medical Group Ltd | 536.52 Million USD | 99.974% |
Ryman Healthcare Limited | 650.53 Million USD | 99.979% |
Stem Cell Authority, Ltd. | - USD | -Infinity% |
SETO Holdings, Inc. | - USD | -Infinity% |
Optima Medical Innovations Corp. | 4.61 Million USD | 97.024% |
Mycotopia Therapies, Inc. | - USD | -Infinity% |
U.S. NeuroSurgical Holdings, Inc. | - USD | -Infinity% |
Veltex Corporation | 838.65 Thousand USD | 83.628% |
World Financial Holding Group | - USD | -Infinity% |
Xcelerate Inc. | 1.12 Million USD | 87.763% |